Prenuvo is a medical startup specializing in early detection of cancer and various diseases through innovative magnetic resonance imaging (MRI) technology. Their advanced scanning method offers a full-body scan within an hour, producing detailed images that can uncover often missed signs of serious illness. By employing such a comprehensive approach, Prenuvo aims to facilitate early diagnosis, significantly improving treatment outcomes and potentially saving lives. Their service is non-invasive and does not involve radiation, making it a safer alternative for patients. Prenuvo's scans are interpreted by specialized radiologists, ensuring accurate and timely health assessments.

Prenuvo

Prenuvo provides MRI scans for early, comprehensive disease detection.

Prenuvo taps $70M Series A

Recent Funding News